NCT03872947 2025-08-03A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsToray Industries, IncPhase 1 Active not recruiting138 enrolled
NCT00721162 2019-09-26Study of Ramucirumab in Ovarian CancerEli Lilly and CompanyPhase 2 Completed60 enrolled 14 charts